Adam Elzagheid

1.1k total citations
50 papers, 668 citations indexed

About

Adam Elzagheid is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Adam Elzagheid has authored 50 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Adam Elzagheid's work include Genetic factors in colorectal cancer (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Wnt/β-catenin signaling in development and cancer (8 papers). Adam Elzagheid is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Wnt/β-catenin signaling in development and cancer (8 papers). Adam Elzagheid collaborates with scholars based in Libya, Finland and Iran. Adam Elzagheid's co-authors include Seppo Pyrhönen, Yrjö Collan, Karí Syrjänen, Abdelbaset Buhmeida, Eija Korkeila, Nureddin Ashammakhi, Riyad Bendardaf, Teijo Kuopio, Mohammed Elmusrati and James S. Tomlinson and has published in prestigious journals such as PLoS ONE, Small and European Journal of Cancer.

In The Last Decade

Adam Elzagheid

45 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Elzagheid Libya 14 271 265 123 89 80 50 668
Liang Peng China 16 310 1.1× 251 0.9× 43 0.3× 44 0.5× 149 1.9× 78 843
Zhirong Qian China 16 383 1.4× 235 0.9× 108 0.9× 23 0.3× 183 2.3× 24 759
Wenyu Li China 15 196 0.7× 275 1.0× 213 1.7× 39 0.4× 89 1.1× 81 738
Kristen E. Muller United States 15 196 0.7× 275 1.0× 88 0.7× 31 0.3× 162 2.0× 42 587
Qiuhui Li China 11 221 0.8× 229 0.9× 60 0.5× 39 0.4× 113 1.4× 26 508
Francesca Romana Mariotti Italy 17 298 1.1× 565 2.1× 49 0.4× 32 0.4× 72 0.9× 32 1.2k
Zhenqing Feng China 16 386 1.4× 295 1.1× 91 0.7× 19 0.2× 147 1.8× 43 786
Feng Tang China 16 436 1.6× 314 1.2× 104 0.8× 22 0.2× 235 2.9× 34 849
Wanhong Zhao China 17 396 1.5× 432 1.6× 72 0.6× 54 0.6× 196 2.5× 54 978
Saravanan Yuvaraj Netherlands 12 356 1.3× 155 0.6× 216 1.8× 27 0.3× 60 0.8× 16 807

Countries citing papers authored by Adam Elzagheid

Since Specialization
Citations

This map shows the geographic impact of Adam Elzagheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Elzagheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Elzagheid more than expected).

Fields of papers citing papers by Adam Elzagheid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Elzagheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Elzagheid. The network helps show where Adam Elzagheid may publish in the future.

Co-authorship network of co-authors of Adam Elzagheid

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Elzagheid. A scholar is included among the top collaborators of Adam Elzagheid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Elzagheid. Adam Elzagheid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Attitalla, Idress Hamad, et al.. (2025). Post-Acute COVID-19 Pathophysiology: Cellular Stress Responses, Immune Dysregulation, and Biochemical Signatures in Recovery Phase. Cellular Physiology and Biochemistry. 59(4). 485–495.
2.
Nolan, Christopher C., et al.. (2024). Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. 206(1). 143–153. 7 indexed citations
3.
Elzagheid, Adam, et al.. (2024). Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya. Libyan Journal of Medicine. 19(1). 2356906–2356906. 1 indexed citations
4.
Elzagheid, Adam, et al.. (2024). Single ChAdOx1 nCoV‐19 dose elicits stronger immune response in previously infected individuals than in SARS‐CoV2 naive persons. Immunity Inflammation and Disease. 12(1). e1159–e1159.
5.
Rutland, Paul, et al.. (2023). Screening of interleukin 17F gene polymorphisms and eight subgingival pathogens in chronic periodontitis in Libyan patients. Libyan Journal of Medicine. 18(1). 2225252–2225252. 2 indexed citations
6.
Elzagheid, Adam, et al.. (2022). Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines. Vaccines. 10(12). 2002–2002. 9 indexed citations
7.
Elzagheid, Adam, et al.. (2020). Breast cancer in western part of Libya: Pattern and management (2003-2018). 4(2). 65–65. 4 indexed citations
8.
9.
Ashammakhi, Nureddin & Adam Elzagheid. (2018). Organ-on-a-Chip: New Tool for Personalized Medicine. Journal of Craniofacial Surgery. 29(4). 823–824. 19 indexed citations
10.
Elzagheid, Adam, et al.. (2017). Seroprevalence of Foot and Mouth Disease, Blue Tongue Disease and Camel Brucellosis in Animals Imported into Libya. Alexandria Journal of Veterinary Sciences. 54(1). 97–97. 2 indexed citations
11.
Elzagheid, Adam, et al.. (2016). Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma. Anticancer Research. 36(10). 5301–5306. 3 indexed citations
12.
Elzagheid, Adam, Abdelbaset Buhmeida, Matti Laato, et al.. (2012). Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumor Biology. 34(2). 621–628. 25 indexed citations
13.
Syrjänen, Karí, et al.. (2012). Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. Libyan Journal of Medicine. 7(1). 14694–14694. 12 indexed citations
14.
Ibrahim, Nader, et al.. (2009). The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder. Libyan Journal of Medicine. 4(4). 143–5. 6 indexed citations
15.
Elzagheid, Adam, Eija Korkeila, Riyad Bendardaf, et al.. (2008). Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Human Pathology. 39(12). 1737–1743. 81 indexed citations
16.
Buhmeida, Abdelbaset, Adam Elzagheid, Annika Ålgars, et al.. (2008). Expression of the cell‐cell adhesion molecule β‐catenin in colorectal carcinomas and their metastases. Apmis. 116(1). 1–9. 16 indexed citations
17.
Elzagheid, Adam, Abdelbaset Buhmeida, Eija Korkeila, et al.. (2008). Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma. World Journal of Gastroenterology. 14(24). 3866–3866. 53 indexed citations
18.
Bendardaf, Riyad, Adam Elzagheid, Hanan Lamlum, et al.. (2006). Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases. Scandinavian Journal of Gastroenterology. 42(4). 471–476. 7 indexed citations
19.
Elzagheid, Adam, Teijo Kuopio, Seppo Pyrhönen, & Yrjö Collan. (2006). Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?. Diagnostic Pathology. 1(1). 41–41. 17 indexed citations
20.
Bendardaf, Riyad, Adam Elzagheid, H. Lamlum, et al.. (2005). E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer. Oncology Reports. 13(5). 831–5. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Peng Breakdown of academic impact, for papers by Zhirong Qian Breakdown of academic impact, for papers by Wenyu Li Breakdown of academic impact, for papers by Kristen E. Muller Breakdown of academic impact, for papers by Qiuhui Li Breakdown of academic impact, for papers by Francesca Romana Mariotti Breakdown of academic impact, for papers by Zhenqing Feng Breakdown of academic impact, for papers by Feng Tang Breakdown of academic impact, for papers by Wanhong Zhao Breakdown of academic impact, for papers by Saravanan Yuvaraj
Rankless by CCL
2026